BrightSpring Health Services Inc

BrightSpring insiders fine‑tune holdings amid bullish momentum—how ROUSSEAU’s recent 16k‑share sale and option activity could affect short‑term liquidity and investor confidence.

BrightSpring insider Robert Allen’s recent sale shows liquidity moves amid steady growth, with option buying hinting at long‑term confidence.

BrightSpring insider buys at $6.37 reveal executive confidence amid 158% rally—insider activity signals future upside for specialty pharmacy and imaging growth.

KKR’s $819 M secondary offering fuels BrightSpring’s expansion while a 19‑million‑share sale tests investor confidence—what it means for growth and governance.